Tau deletion prevents stress-induced dendritic atrophy in prefrontal cortex: Role of synaptic mitochondria

Cerebral Cortex

Volumn 27, Issue 4, 2017, Pages 2580-2591

  Lopes, Sofia ^a,b   Teplytska, Larysa ^c   Vaz Silva, Joao ^a,b   Dioli, Chrysoula ^a,b   Trindade, Rita ^a,b   Morais, Monica ^a,b   Webhofer, Christian ^c,d   MaCcarrone, Giuseppina ^c   Almeida, Osborne F X ^c   Turck, Christoph W ^c   Sousa, Nuno ^a,b   Sotiropoulos, Ioannis ^a,b   Filiou, Michaela D ^c  

^a UNIVERSITY OF MINHO   (Portugal)

^b UNIVERSITY OF MINHO   (Portugal)

^c MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^d Sandoz Biopharmaceuticals   (Germany)

Author keywords

Chronic stress; Dendritic atrophy; Mitochondria; Prefrontal cortex; Tau knock out

Indexed keywords

MITOCHONDRIAL PROTEIN; TAU PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATROPHY; BRAIN MITOCHONDRION; CELLULAR DISTRIBUTION; CHRONIC STRESS; COGNITIVE DEFECT; CONTROLLED STUDY; DENDRITE; DENDRITIC ATROPHY; GENE INACTIVATION; GENOTYPE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IN VIVO STUDY; LOCOMOTION; MALE; MEMORY; MEMORY DISORDER; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; OPEN FIELD TEST; OXIDATIVE PHOSPHORYLATION; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; RESPIRATORY CHAIN; STRUCTURE ANALYSIS; SYNAPSE; SYNAPTOSOME; TRANSMISSION ELECTRON MICROSCOPY; WORKING MEMORY; Y-MAZE TEST; ANIMAL; C57BL MOUSE; COMPLICATION; DISEASE MODEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KNOCKOUT MOUSE; MASS SPECTROMETRY; MENTAL STRESS; METABOLISM; MITOCHONDRION; PATHOLOGY; ULTRASTRUCTURE;

ANIMALS; ATROPHY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DENDRITES; DISEASE MODELS, ANIMAL; MALE; MASS SPECTROMETRY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, ELECTRON, TRANSMISSION; MITOCHONDRIA; PREFRONTAL CORTEX; PROTEOMICS; STRESS, PSYCHOLOGICAL; SYNAPSES; TAU PROTEINS;

EID: 85019231282     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhw057     Document Type: Article

References (73)

1. Atlante A, Amadoro G, Bobba A, de Bari L, Corsetti V, Pappalardo G, Marra E, Calissano P, Passarella S. 2008. A peptide containing residues 26-44 of tau protein impairs mitochondrial oxidative phosphorylation acting at the level of the adenine nucleotide translocator. Biochim Biophys Acta. 1777:1289-1300.
2. Bessa JM, Ferreira D, Melo I, Marques F, Cerqueira JJ, Palha JA, Almeida OF, Sousa N. 2009. The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. Mol Psychiatry. 14:764-773. 739.
3. Bifulco M, Laezza C, Stingo S, Wolff J. 2002. 2',3'-Cyclic nucleotide 3'-phosphodiesterase: a membrane-bound, microtubule-associated protein and membrane anchor for tubulin. Proc Natl Acad Sci USA. 99:1807-1812.
4. Bisgaard CF, Bak S, Christensen T, Jensen ON, Enghild JJ, Wiborg O. 2012. Vesicular signalling and immune modulation as hedonic fingerprints: proteomic profiling in the chronic mild stress depression model. J Psychopharmacol. 26:1569-1583.
5. Catania C, Sotiropoulos I, Silva R, Onofri C, Breen KC, Sousa N, Almeida OF 2009. The amyloidogenic potential and behavioral correlates of stress. Mol Psychiatry. 14:95-105.
6. Cereseto M, Reines A, Ferrero A, Sifonios L, Rubio M, Wikinski S. 2006. Chronic treatment with high doses of corticosterone decreases cytoskeletal proteins in the rat hippocampus. Eur J Neurosci. 24:3354-3364.
7. Cerqueira JJ, Mailliet F, Almeida OFX, Jay TM, Sousa N. 2007. The prefrontal cortex as a key target of the maladaptive response to stress. J Neurosci. 27:2781-2787.
8. Cerqueira JJ, Taipa R, Uylings HB, Almeida OF, Sousa N. 2007. Specific configuration of dendritic degeneration in pyramidal neurons of the medial prefrontal cortex induced by differing corticosteroid regimens. Cereb Cortex. 17:1998-2006.
9. Chauhan NB, Lee JM, Siegel GJ. 1997. Na,K-ATPasemRNA levels and plaque load in Alzheimer's disease. J Mol Neurosci. 9:151-166.
10. Cheng A, Hou Y, Mattson MP 2010. Mitochondria and neuroplasticity. ASN Neuro. 2:e00045.
11. Chihara T, Luginbuhl D, Luo L. 2007. Cytoplasmic and mitochondrial protein translation in axonal and dendritic terminal arborization. Nat Neurosci. 10:828-837.
12. Cho DH, Nakamura T, Fang J, Cieplak P, Godzik A, Gu Z, Lipton SA 2009. S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrialfission and neuronal injury. Science. 324:102-105.
13. David DC, Hauptmann S, Scherping I, Schuessel K, Keil U, Rizzu P, Ravid R, Drose S, Brandt U, Muller WE, et al. 2005. Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice. J Biol Chem. 280:23802-23814.
14. Dawson HN, Ferreira A, Eyster MV, Ghoshal N, Binder LI, Vitek MP 2001. Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice. J Cell Sci. 114:1179-1187.
15. Du J, Wang Y, Hunter R, Wei Y, Blumenthal R, Falke C, Khairova R, Zhou R, Yuan P, Machado-Vieira R, et al 2009. Dynamic regulation of mitochondrial function by glucocorticoids. Proc Natl Acad Sci USA. 106:3543-3548.
16. Edeas M, Weissig V. 2013. Targeting mitochondria: strategies, innovations and challenges: The future of medicine will come through mitochondria. Mitochondrion. 13:389-390.
17. Einat H, Yuan P, Manji HK 2005. Increased anxiety-like behaviors and mitochondrial dysfunction in mice with targeted mutation of the Bcl-2 gene: further support for the involvement of mitochondrial function in anxiety disorders. Behav Brain Res. 165:172-180.
18. 15N metabolic labeling for schizophrenia research. Arch Clin Psychiatry. 40:51-52.
19. Filiou MD, Bisle B, Reckow S, Teplytska L, Maccarrone G, Turck CW 2010. Profiling of mouse synaptosome proteome and phosphoproteome by IEF. Electrophoresis. 31:1294-1301.
20. Filiou MD, Teplytska L, Otte DM, Zimmer A, Turck CW. 2012. Myelination and oxidative stress alterations in the cerebellum of the G72/G30 transgenic schizophrenia mouse model. J Psychiatr Res. 46:1359-1365.
21. Filiou MD, Turck CW 2012. Psychiatric disorder biomarker discovery using quantitative proteomics. Methods Mol Biol. 829:531-539.
22. Filiou MD, Zhang Y, Teplytska L, Reckow S, Gormanns P, Maccarrone G, Frank E, Kessler MS, Hambsch B, Nussbaumer M, et al 2011. Proteomics and metabolomics analysis of a trait anxiety mouse model reveals divergent mitochondrial pathways. Biol Psychiatry. 70:1074-1082.
23. Frandemiche ML, De Seranno S, Rush T, Borel E, Elie A, Arnal I, Lante F, Buisson A. 2014. Activity-dependent tau protein translocation to excitatory synapse is disrupted by exposure to amyloid-beta oligomers. J Neurosci. 34:6084-6097.
24. Frank E, Kessler MS, Filiou MD, Zhang Y, Maccarrone G, Reckow S, Bunck M, Heumann H, Turck CW, Landgraf R, et al. 2009. Stable isotope metabolic labeling with a novel N-enriched bacteria diet for improved proteomic analyses of mouse models for psychopathologies. . PLoS ONE. 4:e7821.
25. Fulda S, Galluzzi L, Kroemer G. 2010. Targeting mitochondria for cancer therapy. Nat Rev Drug Discov. 9:447-464.
26. Gardner A, Johansson A, Wibom R, Nennesmo I, von Dobeln U, Hagenfeldt L, Hallstrom T. 2003. Alterations of mitochondrial function and correlations with personality traits in selected major depressive disorder patients. J Affect Disord. 76:55-68.
27. Gotz J, Xia D, Leinenga G, Chew YL, Nicholas H. 2013. What Renders TAU Toxic. Front Neurol. 4:72.
28. Harada A, Oguchi K, Okabe S, Kuno J, Terada S, Ohshima T, Sato-Yoshitake R, Takei Y, Noda T, Hirokawa N. 1994. Altered microtubule organization in small-calibre axons of mice lacking tau protein. Nature. 369:488-491.
29. Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, van Eersel J, Wolfing H, Chieng BC, Christie MJ, Napier IA, et al 2010. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell. 142:387-397.
30. Ke YD, Suchowerska AK, van der Hoven J, De Silva DM, Wu CW, van Eersel J, Ittner A, Ittner LM. 2012. Lessons from taudeficient mice. Int J Alzheimers Dis. 2012:873270.
31. Kimura T, Yamashita S, Fukuda T, Park JM, Murayama M, Mizoroki T, Yoshiike Y, Sahara N, Takashima A. 2007. Hyperphosphorylated tauinparahippocampal cortex impairs place learning in aged mice expressing wild-type human tau. EMBO J. 26:5143-5152.
32. Lee SH, Kim KR, Ryu SY, Son S, Hong HS, Mook-Jung I, Ho WK 2012. Impaired short-term plasticity in mossy fiber synapses caused by mitochondrial dysfunction of dentate granule cells is the earliest synaptic deficit in a mouse model of Alzheimer's disease. J Neurosci. 32:5953-5963.
33. Lopes S, Lopes A, Pinto V, Guimarães MR, Sardinha MR, Duarte-Silva S, Pinheiro S, Pizarro J, Oliveira JF, Sousa N, et al 2016. Absence of Tau triggers age-dependent sciatic nerve morphofunctional deficits and motor impairment Aging Cell. 15:208-216.
34. Lu T, Aron L, Zullo J, Pan Y, Kim H, Chen Y, Yang TH, Kim HM, Drake D, Liu XS, et al 2014. REST and stress resistance in ageing and Alzheimer's disease. Nature. 507:448-454.
35. Ma QL, Zuo X, Yang F, Ubeda OJ, Gant DJ, Alaverdyan M, Kiosea NC, Nazari S, Chen PP, Nothias F, et al 2014. Loss of MAP function leads to hippocampal synapse loss and deficits in the Morris Water Maze with aging. J Neurosci. 34:7124-7136.
36. MacAskill AF, Rinholm JE, Twelvetrees AE, Arancibia-Carcamo IL, Muir J, Fransson A, Aspenstrom P, Attwell D, Kittler JT 2009. Miro1 is a calcium sensor for glutamate receptor-dependent localization of mitochondria at synapses. Neuron. 61:541-555.
37. Magarinos AM, McEwen BS 1995a. Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: comparison of stressors. Neuroscience. 69:83-88.
38. Magarinos AM, McEwen BS 1995b. Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involvement of glucocorticoid secretion and excitatory amino acid receptors. Neuroscience. 69:89-98.
39. Martin KP, Wellman CL 2011. NMDA receptor blockade alters stress-induced dendritic remodeling in medial prefrontal cortex. Cereb Cortex. 21:2366-2373.
40. McEwen BS, Morrison JH 2013. The brain on stress: vulnerability and plasticity of the prefrontal cortex over the life course. Neuron. 79:16-29.
41. McInnes J. 2013. Insights on altered mitochondrial function and dynamics in the pathogenesis of neurodegeneration. Transl Neurodegener. 2:12.
42. Morris M, Hamto P, Adame A, Devidze N, Masliah E, Mucke L. 2013. Age-appropriate cognition and subtle dopamine-independent motor deficits in aged tau knockout mice. Neurobiol Aging. 34:1523-1529.
43. Morris M, Maeda S, Vossel K, Mucke L. 2011. The many faces of tau. Neuron. 70:410-426.
44. Moseley AE, Williams MT, Schaefer TL, Bohanan CS, Neumann JC, Behbehani MM, Vorhees CV, Lingrel JB 2007. Deficiency in Na,K-ATPase alpha isoform genes alters spatial learning, motor activity, and anxiety in mice. J Neurosci. 27:616-626.
45. Mozhui K, Karlsson RM, Kash TL, Ihne J, Norcross M, Patel S, Farrell MR, Hill EE, Graybeal C, Martin KP, et al 2010. Strain differences in stress responsivity are associated with divergent amygdala gene expression and glutamate-mediated neuronal excitability. J Neurosci. 30:5357-5367.
46. Nussbaumer M, Asara JM, Teplytska L, Murphy MP, Logan A, Turck CW, Filiou MD 2015. Selective mitochondrial targeting exerts anxiolytic effects in vivo. Neuropsychopharmacology. Epub Nov 16.
47. Otte DM, Sommersberg B, Kudin A, Guerrero C, Albayram O, Filiou MD, Frisch P, Yilmaz O, Drews E, Turck CW, et al 2011. N-acetyl cysteine treatment rescues cognitive deficits induced by mitochondrial dysfunction in G72/G30 transgenic mice. Neuropsychopharmacology. 36:2233-2243.
48. Pan C, Kora G, McDonald WH, Tabb DL, VerBerkmoes NC, Hurst GB, Pelletier DA, Samatova NF, Hettich RL 2006. ProRata: a quantitative proteomics program for accurate protein abundance ratio estimation with confidence interval evaluation. Anal Chem. 78:7121-7131.
49. Pawlak R, Rao BS, Melchor JP, Chattarji S, McEwen B, Strickland S. 2005. Tissue plasminogen activatorandplasminogen mediate stress-induced decline of neuronal and cognitive functions in the mouse hippocampus. Proc Natl Acad Sci U S A. 102:18201-18206.
50. Rapoport M, Dawson HN, Binder LI, Vitek MP, Ferreira A. 2002. Tau is essential to beta-amyloid-induced neurotoxicity. Proc Natl Acad Sci U S A. 99:6364-6369.
51. Rezin GT, Amboni G, Zugno AI, Quevedo J, Streck EL 2009. Mitochondrial dysfunction and psychiatric disorders. Neurochem Res. 34:1021-1029.
52. Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, Gerstein H, Yu GQ, Mucke L. 2007. Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science. 316:750-754.
53. Rudolf GD, Cronin CA, Landwehrmeyer GB, Standaert DG, Penney JB Jr, Young AB 1996. Expression of N-methyl-D-aspartate glutamate receptor subunits in the prefrontal cortex of the rat. Neuroscience. 73:417-427.
54. Sarnyai Z, Sibille EL, Pavlides C, Fenster RJ, McEwen BS, Toth M. 2000. Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin(1A) receptors. Proc Natl Acad Sci USA. 97: 14731-14736.
55. Schrimpf SP, Meskenaite V, Brunner E, Rutishauser D, Walther P, Eng J, Aebersold R, Sonderegger P. 2005. Proteomic analysis of synaptosomes using isotope-coded affinity tags and mass spectrometry. Proteomics. 5:2531-2541.
56. Schulz KL, Eckert A, Rhein V, Mai S, Haase W, Reichert AS, Jendrach M, Muller WE, Leuner K. 2012. A new linktomitochon-drial impairment in tauopathies. Mol Neurobiol. 46:205-216.
57. Shahpasand K, Uemura I, Saito T, Asano T, Hata K, Shibata K, Toyoshima Y, Hasegawa M, Hisanaga S. 2012. Regulation of mitochondrial transport and inter-microtubule spacing by tau phosphorylation at the sites hyperphosphorylated in Alzheimer's disease. J Neurosci. 32:2430-2441.
58. Shao L, Martin MV, Watson SJ, Schatzberg A, Akil H, Myers RM, Jones EG, Bunney WE, Vawter MP 2008. Mitochondrial involvement in psychiatric disorders. Ann Med. 40:281-295.
59. Sotiropoulos I, Catania C, Pinto LG, Silva R, Pollerberg GE, Takashima A, Sousa N, Almeida OF 2011. Stress acts cumulatively to precipitate Alzheimer's disease-like tau pathology and cognitive deficits. J Neurosci. 31:7840-7847.
60. Sotiropoulos I, Catania C, Riedemann T, Fry JP, Breen KC, Michaelidis TM, Almeida OF 2008. Glucocorticoids trigger Alzheimer disease-like pathobiochemistry in rat neuronal cells expressing human tau. J Neurochem. 107:385-397.
61. Sotiropoulos I, Cerqueira JJ, Catania C, Takashima A, Sousa N, Almeida OF 2008. Stress and glucocorticoid footprints in the brain-the path from depression to Alzheimer's disease. Neurosci Biobehav Rev. 32:1161-1173.
62. Sousa N, Almeida OF 2012. Disconnection and reconnection: the morphological basis of (mal)adaptation to stress. Trends Neurosci. 35:742-751.
63. Szego EM, Janaky T, Szabo Z, Csorba A, Kompagne H, Wuller G, Levay G, Simor A, Juhasz G, Kekesi KA 2010. A mouse model of anxiety molecularly characterized by altered protein networks in the brain proteome. Eur Neuropsychopharmacol. 20:96-111.
64. Takei Y, Teng J, Harada A, Hirokawa N. 2000. Defects in axonal elongation and neuronal migration in mice with disrupted tau and map1b genes. J Cell Biol. 150:989-1000.
65. Toescu EC, Verkhratsky A. 2004. Ca2+ and mitochondria as substrates for deficits in synaptic plasticity in normal brain ageing. J Cell Mol Med. 8:181-190.
66. Vickers JC, Huntley GW, Edwards AM, Moran T, Rogers SW, Heinemann SF, Morrison JH 1993. Quantitative localization of AMPA/kainate and kainate glutamate receptor subunit immunoreactivity in neurochemically identified subpopulations of neurons in the prefrontal cortex of the macaque monkey. J Neurosci. 13:2982-2992.
67. Vitvitsky VM, Garg SK, Keep RF, Albin RL, Banerjee R. 2012. Na+ and K+ ion imbalances in Alzheimer's disease. Biochim Biophys Acta. 1822:1671-1681.
68. Vossel KA, Xu JC, Fomenko V, Miyamoto T, Suberbielle E, Knox JA, Ho K, Kim DH, Yu GQ, Mucke L. 2015. Tau reduction prevents Abeta-induced axonal transport deficits by blocking activation of GSK3beta. J Cell Biol. 209:419-433.
69. Vossel KA, Zhang K, Brodbeck J, Daub AC, Sharma P, Finkbeiner S, Cui B, Mucke L. 2010. Tau reduction prevents Abeta-induced defects in axonal transport. Science. 330:198.
70. Yang J, Hu LL, Song TS, Liu Y, Wu QH, Zhao LY, Liu LY, Zhao XG, Zhang DZ, Huang C. 2014. Proteomic changes in female rat hippocampus following exposure to a terrified sound stress. J Mol Neurosci. 53:158-165.
71. Yuan A, Kumar A, Peterhoff C, Duff K, Nixon RA 2008. Axonal transport rates in vivo are unaffected by tau deletion or over-expression in mice. J Neurosci. 28:1682-1687.
72. Zacharias U, Leuschner R, Norenberg U, Rathjen FG 2002. Tenascin-R induces actin-rich microprocesses and branches along neurite shafts. Mol Cell Neurosci. 21:626-633.
73. Zempel H, Luedtke J, Kumar Y, Biernat J, Dawson H, Mandelkow E, Mandelkow EM. 2013. Amyloid-beta oligomers induce synaptic damage via Tau-dependent microtubule severing by TTLL6 and spastin. EMBO J. 32:2920-2937.